Celadon Pharmaceuticals Plc (LON:CEL – Get Free Report)’s share price fell 25.3% during mid-day trading on Friday . The stock traded as low as GBX 13 ($0.16) and last traded at GBX 13.45 ($0.17). 124,310 shares traded hands during mid-day trading, a decline of 66% from the average session volume of 362,092 shares. The stock had previously closed at GBX 18 ($0.22).
Celadon Pharmaceuticals Stock Down 26.2 %
The firm has a market cap of £9.15 million, a price-to-earnings ratio of -166.13 and a beta of -0.26. The stock’s 50 day moving average is GBX 17.46 and its 200 day moving average is GBX 30.39. The company has a quick ratio of 6.97, a current ratio of 1.92 and a debt-to-equity ratio of 194.82.
About Celadon Pharmaceuticals
Celadon Pharmaceuticals Plc is a UK-based pharmaceutical company focused on the development, production and sale of breakthrough cannabis-based medicines. Its primary focus is on improving quality of life for chronic pain sufferers, as well as exploring the potential of cannabis-based medicines for other conditions such as autism.
Featured Articles
- Five stocks we like better than Celadon Pharmaceuticals
- Dividend Payout Ratio Calculator
- How Growth Investors Find High-Growth Stocks and Maximize Returns
- What Are Growth Stocks and Investing in Them
- Meta’s AI & Smart Glasses Could Drive 20%+ Upside in 2025
- The Significance of Brokerage Rankings in Stock Selection
- NVIDIA’s Slide Continues: Can Retail Investors Stop the Fall?
Receive News & Ratings for Celadon Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celadon Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
